BioCentury
ARTICLE | Financial News

XBiotech completes direct public offering

March 9, 2017 12:50 PM UTC

Antibody company XBiotech Inc. (NASDAQ:XBIT) raised $31.9 million through the sale of 2.5 million shares at $13 in a registered direct offering with accredited investors on March 3....

BCIQ Company Profiles

XBiotech Inc.